Clinuvel Pharmaceuticals reported AUD3.85M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Avita Medical AUD 19.03M 1.95M Dec/2025
Medical Developments International AUD 2.84M 4.19M Dec/2025
Mesoblast USD 28.54M 9.69M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Pacific Edge NZD 16.75M 2.42M Jun/2026
Paradigm Biopharmaceuticals AUD 2.83M 1.22M Dec/2025
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Telix Pharmaceuticals AUD 93.48M 1.04M Dec/2025